Capricor Therapeutics

1 follower


Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the development of cell and exosome-based therapeutics for the treatment and prevention of serious diseases.

Industries

Employees

11-50

Links

Org chart

Linda Marbán
Chief Executive Officer

Linda Marbán

Collapse
Aj Bergmann
Chief Financial Officer
Kristi A. H. Elliott
Chief Science Officer
Mark Awadalla
Chief Development Officer (cdo)
Yushi Feng
VP of Regulatory Affairs
Jonathan Tayco
Vice President Of Program Management, Operations And Quality
Joe Z.
Senior IP Counsel

Board & advisors

Eugenio Mercuri
Scientific Advisor
Oscar Henry Mayer
Scientific Advisor
Pat Furlong
Scientific Advisor
Michelle Eagle
Scientific Advisor
Michael Taylor
Scientific Advisor
Francesco Muntoni
Scientific Advisor
Craig McDonald
Scientific Advisor
Chet Villa
Scientific Advisor
Timothy Franson
Scientific Advisor
Suzanne Hendrix
Scientific Advisor